Thomas e Darcy
Director and Chairman of the Audit Committee of Viracta Therapeutics, Inc at Viracta Therapeutics, Inc
Based in San Diego, United States
7-day free trial · no credit card
Seniority
Director
Department
General Business & Management
Location
San Diego
Industry
Biotechnology Research
Company size
47
Contact information
Reveal Thomas's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
t•••••••@viracta.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Thomas e Darcy
Mr. Darcy has 50 years of experience in finance and accounting. He currently serves as a director and chairman of the audit committee, as well as a member of the compensation committee, of Viracta Therapeutics, Inc, a public clinical-stage precision oncology company, and as a director and chairman of the audit committee of Lytx, Inc, a private technology company that is the global leader in video telematics and safety for the commercial and public transportation sectors. Mr. Darcy was also a director, co-founder and retired Executive Vice President and Chief Financial Officer of Tocagen Inc, a cancer-selective gene therapy company that merged with Forte Biosciences, Inc.(Forte) in June of 2020, and served as a director and member of the audit committee of Forte through May of 2021.Prior to co-founding Tocagen, Mr. Darcy served for over five years as Executive Vice President and Chief Financial Officer of Science Applications International Corporation (SAIC), a NYSE Fortune 500 science and technology company. Mr. Darcy also served as a director and the chairman of the audit committee of McAfee, Inc, a NYSE company, for over three years until its sale to Intel for $7.7 billion in February of 2011. Prior to that he was a Partner in the accounting firm of PricewaterhouseCoopers LLP where he served as the Managing Partner of both the West and Southwest Region Audit and Business Advisory Service Technology practices, as well as the Managing Partner of the San Diego office. During his twenty-seven year career with the firm he served as the lead client partner for numerous High Technology and Life Sciences clients such as Qualcomm, Compaq Computer, SAIC, The Walt Disney Company, Agouron Pharmaceuticals, Synbiotics, Canji, SIBIA Neurosciences, and Telios Pharmaceuticals, and assisted his clients with venture capital, public offering and acquisition transactions, including Qualcomm’s, Agouron Pharmaceuticals and Synbiotics initial public offerings. He also developed the firm’s first professional education course on initial public offerings and co-authored the firm’s companion handbook titled “Taking Your Company Public.” He is a Certified Public Accountant (Inactive) and held a Chartered Global Management Accountant (CGMA) designation when he was an Active CPA. Mr. Darcy is the recipient of the San Diego Business Journal "2019 CFO of the Year Lifetime Achievement Award."
Decision-makers
Other people at Viracta Therapeutics, Inc
- BNVp
Biljana Nadjsombati
Vice President, Pharmaceutical Development · Science
- AKDirector
Afton Katkov
Director Clinical Operations · Operations
- MWStaff
Michelline Wachter
Senior Associate, Regulatory Affairs · Legal
- VAVp
Violetta Akopian
Vice President Quality Assurance · Information Technology
- NFDirector
Natalie Fernandez
Project Manager and Head of Patient Advocacy · General Business & Management
Build a list of verified contacts at Viracta Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Thomas
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime